A detailed history of Syon Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Syon Capital LLC holds 11,150 shares of LLY stock, worth $9.66 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
11,150
Previous 10,788 3.36%
Holding current value
$9.66 Million
Previous $6.29 Billion 37.94%
% of portfolio
0.82%
Previous 0.64%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $214,376 - $286,805
362 Added 3.36%
11,150 $8.67 Billion
Q4 2023

Feb 02, 2024

BUY
$525.19 - $619.13 $669,092 - $788,771
1,274 Added 13.39%
10,788 $6.29 Billion
Q3 2023

Nov 03, 2023

BUY
$434.7 - $599.3 $4.14 Million - $5.7 Million
9,514 New
9,514 $5.11 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $823B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Syon Capital LLC Portfolio

Follow Syon Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syon Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syon Capital LLC with notifications on news.